Benzinga's Top Upgrades


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


 

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

  • Deutsche Bank upgraded Goldman Sachs Group Inc (NYSE: GS) from Hold to Buy. The price target for Goldman Sachs has been raised from $180 to $255. Goldman Sachs shares rose 0.94 percent to $213.75 in pre-market trading.
  • Barclays upgraded Charles River Laboratories Intl. Inc (NYSE: CRL) from Underweight to Equal-Weight. Charles River shares closed at $71.56 on Tuesday.
  • Goldman Sachs upgraded Celanese Corporation (NYSE: CE) from Neutral to Buy. The price target for Celanese has been raised from $83 to $92. Celanese shares rose 0.73 percent to close at $77.16 on Tuesday.
  • Analysts at Berenberg upgraded Teck Resources Ltd (USA) (NYSE: TCK) from Sell to Hold. Teck Resources shares gained 1.27 percent to $25.52 in pre-market trading.
  • Analysts at BMO Capital upgraded Mid-America Apartment Communities Inc (NYSE: MAA) from Market Perform to Outperform. Mid-America Apartment shares rose 0.66 percent to $94.43 in pre-market trading.
  • Mizuho upgraded UnitedHealth Group Inc (NYSE: UNH) from Neutral to Buy. UnitedHealth shares rose 0.36 percent to $158.16 in pre-market trading.
  • Analysts at DA Davidson upgraded Super Micro Computer, Inc. (NASDAQ: SMCI) from Neutral to Buy. The price target for Super Micro Computer has been raised from $25 to $32. Super Micro Computer shares gained 2.49 percent to $26.75 in pre-market trading.
  • Analysts at Chardan Capital upgraded Arbutus Biopharma Corp (NASDAQ: ABUS) from Neutral to Buy. The price target for Arbutus Biopharma has been raised from $3 to $4. Arbutus Biopharma shares rose 9.43 percent to $2.90 in pre-market trading.
  • JP Morgan upgraded SBA Communications Corporation (NASDAQ: SBAC) from Neutral to Overweight. SBA Communications shares rose 0.19 percent to close at $99.81 on Tuesday.

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Posted In: UpgradesAnalyst RatingsFinancialsResidential REIT'stop upgrades